Filing Details
- Accession Number:
- 0001001250-19-000012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-08 16:27:15
- Reporting Period:
- 2019-02-07
- Accepted Time:
- 2019-02-08 16:27:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1001250 | Estee Lauder Companies Inc | EL | Perfumes, Cosmetics & Other Toilet Preparations (2844) | 112408943 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1428855 | Fabrizio Freda | The Estee Lauder Companies Inc. 767 Fifth Avenue New York NY 10153 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2019-02-07 | 98,262 | $29.04 | 171,436 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2019-02-07 | 91,862 | $152.16 | 79,574 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2019-02-07 | 6,400 | $152.81 | 73,174 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Option (Right to Buy) | Disposition | 2019-02-07 | 98,262 | $0.00 | 98,262 | $29.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2012-01-01 | 2020-09-01 | No | 4 | M | Direct |
Footnotes
- Stock Options granted pursuant to Fiscal 2002 Share Incentive Plan in respect of 82,754 shares exercisable from and after January 1, 2012; 82,754 shares exercisable from and after January 1, 2013; 82,754 shares exercisable from and after January 1, 2014, adjusted to reflect the stock split that occurred on January 20, 2012.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- Sales prices range from $151.75 to $152.74 per share, inclusive.
- Sales prices range from $152.75 to $152.93 per share, inclusive.
- Not applicable.
Billionaire Hedge Funds
